Background/Aim. A 30 year-old woman, treated with buserelin, an analogue of gonadotropin
Introduction
Gastrointestinal motility requires coordination between the intrinsic and extrinsic nervous system, the interstitial Cells of Cajal (ICCs) and smooth muscle cells (1, 2) .
Disturbances in digestive motility can occur as a result of a variety of abnormalities affecting each of these elements (alone or in combination) involved in the physiology of gut motor function (3).
Chronic intestinal pseudo-obstruction (CIPO) is a particularly difficult clinical challenge, characterised by the presence of chronic dysmotility and intestinal dilatation in the absence of mechanical obstruction (4) . There are two main forms of CIPO i.e. myopathic, involving the intestinal musculature, and neurogenic, involving the extrinsic innervation of the gut or intrinsic (enteric) nerves and pacemaker cells (ICCs) (5, 6 ).
Here we report on a patient who participated in an in-vitro fertilization programme (IVF) and who, following repeated pre-treatment with buserelin, a synthetic gonadotropin-releasing hormone (GnRH) agonist (7) , developed a degenerative neuropathic type of CIPO. The patient developed antibodies against buserelin. Our hypothesis is that these antibodies cross-reacted with endogenous GnRH, destroying GnRH-immunoreactive neurons of the myenteric plexus. To our knowledge, this is the first report demonstrating the presence of GnRH-positive neurons in the human gastrointestinal tract.
Materials and Methods

Case report
A 30 year-old woman had been bilaterally salpingectomized due to ectopic pregnancies in 1991-92, complicated by the rupture of the fallopian tubes, and had therefore developed secondary infertility. Her first IVF attempt took place in December 1992 and she was treated with intra-nasal buserelin (total dose 16 mg). The attempt was unsuccessful wherefore a second IVF procedure with intra-nasal buserelin (total dose 24 mg) was initiated in March 1993, but was discontinued after 3 weeks because of excessive uterine bleeding. A third IVF attempt in August 1993 using subcutaneous buserelin (total dose 37.5 mg) was successful and she delivered a child in May 1994.
Six years later the patient desired another child and she was accepted for a fourth IVF programme using subcutaneous buserelin (total dose 17 mg). This was initiated in April 2000. However, the treatment was discontinued after 17 days because of nausea. Two weeks later the patient experienced acute onset of chest and abdominal pain combined with dysphagia. These symptoms progressed, together with vomiting, constipation, bloating and extensive belching. To avoid symptoms she reduced her food intake, resulting in weight loss.
In spite of discontinuing the treatment, her symptoms remained and she had lost 14 kg of body weight. She was then referred to us in December 2000 due to nausea and dysphagia.
Clinical investigation
Esophago-gastro-duodenoscopy (EGD) one month before referral gave normal results. Simultaneous videoradiography of the pharynx (barium swallow) indicated a specific swallowing defect with an initial retention of the bolus, which, after a certain time could pass Ambulatory, 24-h, pH monitoring of the esophagus sphincter indicated mild reflux. As the symptoms intensified she was re-examined by EGD, which showed a mild Helicobacter pylori-induced gastritis, for which eradication treatment was given. Further examination with enterography demonstrated extremely slow passage through both the stomach and small intestine, and intestinal manometry displayed abnormal fasting bursts, which raised the suspicion of CIPO. Gastric emptying scintigraphy performed after ingestion of a meal consisting of egg and bread showed a pronounced gastroparesis. After 70 min, 75% of the content remained in the ventricle (T50 for healthy controls; 40±28 min) (9) . A measurement of the gastric emptying by using a transit method showed that after ingestion of porridge, milk and bread, only 30% of the particles were emptied after 8 h (ref. value for complete emptying: 1.3-5.6 h) (10) . A succeeding diagnostic laparoscopy showed no macroscopic pathology of the small intestine, but a markedly reduced peristalsis was noted.
There were no signs of endometriosis, adhesions, Meckel's diverticulum or tumours. A diamond shaped, full-thickness wall biopsy was taken one metre proximal to the ileocecal valve and was immediately transported in wet compress for pathological examination.
The follow-up period is now 5 years. The dysphagia is unaltered and the patient is incapable of full time work due to abdominal pain, vomiting and nutritional problems. The patient is currently being considered for an implantation of an electric, gastric stimulator.
Histopathology
The biopsy was a piece of full-thickness small intestinal wall, 1.5 x 1.0 cm in size. Following fixation overnight in 4% formalin at room temperature two transverse, fullthickness slices perpendicular to each other were cut and embedded in paraffin for conventional transversal sections. The remaining, larger part of the biopsy was embedded in toto for tangential sectioning, which makes it possible to examine the whole myenteric plexus.
H&E-stained and transversally cut sections were used in order to determine the number of neurons/mm myenteric plexus. All nerve cells containing nuclei and large, unequivocal neuron-bodies without nuclei were counted. Small, suspected neuroncytoplasmic structures were disregarded. The damaged myenteric neurons were counted in both transversal and tangential sections, and were presented as a percentage of the total number of neurons.
Serial sections from all the three blocks were stained according to a protocol for CIPO analysis, which includes different antibodies for neural tissue and smooth muscle cell staining (11) . The specific immunohistochemical stainings were applied for the analysis of neurons (protein gene product 9.5 (PGP 9.5), neurofilaments, synaptophysin, bcl-2, substance P, neuron-specific endolase (NSE) and α-internexin), glial cells and Schwann cells (S100), Tlymphocytes (CD3), intermediate/microfilaments of the smooth muscle cells (α-actin, desmin, vimentin) and the interstitial Cajal-cells (ICCs) (CD117 and CD34). For the negative controls, the specific antibody was replaced by non-immunized serum.
The amount of abnormally stained/negative neurons for PGP9.5 and bcl-2 was determined on tangential sections and is given as the percentage of the total neuron population in these sections.
In addition, the sections were stained with anti-GnRH antibody (anti-LH-RH; PROGEN Biotechnik GmbH, Heidelberg, Germany) at 1:100 dilution, following microwave pre-treatment. The transverse sections were used to determine the amount of GnRH-positive neurons because tangentially cut sections were no longer available. The sections of normal small intestinal tissue from 4 cases of bowel resection due to intestinal carcinomas were used as controls, and were stained as described above.
Assay of human antibodies against GnRH
Serum samples subjected to various microbiological analyses are routinely stored at -40 °C at the Department of Microbiology. A search through her register gave us the possibility to obtain patient serum samples from various years. After the patient had been informed and had given her written consent, the samples were collected and analysed. 
Competitive binding assay of patient anti-GnRH antibody
The assay was carried out as described above except that, after addition of patient serum, a fixed volume of either physiologic saline or buserelin (0.2 mg/mL) was added.
Statistical methods
Values are expressed as mean±SD. The linearity of the standard curve was estimated by linear regression analysis. The significances of the differences in the proportions of neurons between the patient and the controls were obtained using Pearson's chi-squared test. All calculated P values were two-sided.
Results
Histopathological examination
The total number of myenteric neurons was significantly lower in the patient compared to the controls: 5.9 vs 16.9 neurons/mm length of myenteric plexus (p< 0.01).
Twenty percent of the neurons (49 out of 248) of the myenteric plexus in the patient were either swollen, rounded with a smooth surface with or without vacuolation of the cytoplasm, or were shrunken with pyknotic nuclei and amphophilic cytoplasm ( Figure 1A) . The nerve fibres within the muscle layers were thickened and vacuolated. Swollen/vacuolated or shrunken neurons were not observed in the control material.
The damaged neurons also showed an abnormal immunoprofile. Twenty percent of the neurons (15 out of 75) were negative or very weakly stained for protein gene product (PGP9.5) (Fig 1B) and 13% (12 out of 97) for bcl-2. In contrast, in the control material, all neurons were positive for the PGP9.5 and bcl-2. The swollen neurons in the patient showed very strong and diffuse staining for neurofilament and alpha-internexin. The synaptophysinpattern of the degenerating neurons was also abnormal: the neurons were negative and the continuous pericellular layer of strongly positive small vesicles and granules was disrupted or missing. The immunostaining for substance P and NSE was diminished (data not shown). The number of ICCs was markedly increased within the circular muscle with many, quite large, hypertrophic cells. Several ICCs, both within the intermyenteric/periganglional and in the circular muscle, contained vacuoles in the cytoplasm (Figure 2A and B) . 
Human antibodies against GnRH
Linear regression analysis showed a significant correlation between rabbit anti- 
Discussion
Due to the clinical picture and the findings of antroduodenojejunal manometry and histopathological analysis, the patient fulfils the criteria for CIPO (12) (13) (14) . The sudden onset of this disease in a previously seemingly healthy young woman puzzled us. The study of her gynaecology files, revealing her considerable obstetrical history, led us to predict that the treatment with buserelin, a GnRH analogue, might be related to her symptoms. The prediction was further strengthened when it was found that GnRH and GnRH receptor mRNA is present in parasympathetic ganglion cells of the myenteric plexus in rats (15, 16) .
Chronic intestinal pseudo-obstruction is a disease with many different etiological factors, of which drugs may be one (5, 6) . A drug-induced immunologic reaction with the formation of cross-reacting antibodies against endogenous GnRH was postulated.
However, radioimmunoassays (RIAs) using either 125 I-buserelin or In rats, GnRH mRNA has been found in parietal cells of gastric glands, the epithelium of the small and large intestine, and in parasympathetic ganglion cells of the myenteric plexus. In addition, the GnRH receptor has been found in the epithelium of gastric pits (15) and GnRH receptor mRNA in the myenteric neurons in the rat (16) . GnRH has also been detected in rat pancreas (18) . In dog, GnRH has been shown to inhibit the release of gastric secretions and gastrin release (19) , possibly due to diminished vagal activity. To our knowledge, this is the first study revealing the presence of GnRH-positive neurons in the human gastrointestinal tract.
Substitutions in position 6 and 10 of GnRH (pGlu-His-Trp-Ser-Tyr-Gly-LeuArg-Pro-GlyNH 2 ) lead to greater biological activity and increased half-time (20) . Buserelin The indication for treatment with buserelin and other long-acting GnRH analogues (leuprolide, triptorelin, hirsterlin, nafarelin and goserelin) includes, apart from IVF, also endometriosis, polycystic ovary syndrome, prostate cancer, uterine leiomyoma and precocious puberty. Gastrointestinal side effects are considered infrequent (28) but nausea and abdominal pain have been reported in 7-17 % of women treated with buserelin for endometriosis and uterine leiomyoma (27, 29) . In the majority of these patients the gastrointestinal side effects are most likely due to GnRH-induced disturbed motor activity and not antibody development.
In summary, we report a case of CIPO after buserelin treatment for infertility.
The finding of antibodies against GnRH, together with the markedly decreased number of enteric GnRH immunoreactive neurons, offers a basis for the hypothesis that the patient has developed CIPO due to buserelin-induced formation of anti-GnRH antibodies destroying
GnRH-producing neurons of the myenteric plexus. Studies in larger groups of patients are needed to prove our hypothesis. Moreover, the physiological and pathophysiological role of GnRH on gastrointestinal functions deserves further study.
